基本信息
views: 2
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
More than 40 years experience in drug research and higher education (medicinal chemistry). Established validated predictive QSAR methods.Developed patentable kinase inhibitors for SUGEN, AXXIMA, GPC Biotech, Biosignal, Biostatin etc. (> 110 patent applications filed)
Great experience in heterocyclic chemistry and pharmaceutical patents.Developing potential drugs acting as signal transduction inhibitors (antiviral, anticancer, antiinflammatory etc.agents)
Teaching in graduate (pharmacist) and postgraduate (PhD) courses
Specialties: Project management, drug design, chemical synthesis, QSAR, computational screening
Research Interests
Papers共 253 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
L Valdez Capuccino, T Kleitke,B Szokol, L Svajda, F Martin, F Bonechi, M Krekó, S Azami,A Montinaro, Y Wang, V Nikolov, L Kaiser,
Cell death & diseaseno. 5 (2024): 345-345
REACTION CHEMISTRY & ENGINEERINGno. 3 (2024): 583-593
Yi-Xiang Zhang, Peter G. Knyazev,Yuri V. Cheburkin,Kirti Sharma,Yuri P. Knyazev,László Őrfi,István Szabadkai,Henrik Daub,György Kéri,Axel Ullrich
crossref(2023)
crossref(2023)
Yi-Xiang Zhang, Peter G. Knyazev,Yuri V. Cheburkin,Kirti Sharma,Yuri P. Knyazev,László Őrfi,István Szabadkai,Henrik Daub,György Kéri,Axel Ullrich
crossref(2023)
Yi-Xiang Zhang, Peter G. Knyazev,Yuri V. Cheburkin,Kirti Sharma,Yuri P. Knyazev,László Őrfi,István Szabadkai,Henrik Daub,György Kéri,Axel Ullrich
crossref(2023)
crossref(2023)
Reaction Chemistry and Engineering (2023)
International journal of molecular sciencesno. 14 (2023): 11646-11646
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn